Journal Information

Most cited

12
Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
Esther Redondo, Irene Rivero-Calle, Enrique Mascarós, Daniel Ocaña, Isabel Jimeno, Ángel Gil, Manuel Linares, María Ángeles Onieva-García, ... Federico Martinón-Torres
Arch Bronconeumol. 2024;60:161-70
12
Full text access
Open Article
11
Spanish Consensus on Remission in Asthma (REMAS)
Francisco Javier Álvarez-Gutiérrez, Francisco Casas-Maldonado, Gregorio Soto-Campos, Marina Blanco-Aparicio, Julio Delgado, Alicia Padilla Galo, Santiago Quirce, Vicente Plaza
Arch Bronconeumol. 2024;60:503-9
11
Full text access
10
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Marcela Valverde-Monge, Patricia Sánchez-Carrasco, Diana Betancor, Blanca Barroso, José Manuel Rodrigo-Muñoz, Ignacio Mahillo-Fernández, Ebymar Arismendi, Irina Bobolea, ... Joaquín Sastre
Arch Bronconeumol. 2024;60:23-32
10
Full text access
Open Article
6
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Javier de Miguel-Díez, Julio Núñez Villota, Salud Santos Pérez, Nicolás Manito Lorite, Bernardino Alcázar Navarrete, Juan Francisco Delgado Jiménez, Juan José Soler-Cataluña, Domingo Pascual Figal, ... Juan José Gómez Doblas
Arch Bronconeumol. 2024;60:226-37
6
Full text access
Open Article
5
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Alberto Papi, Franco Alfano, Tommaso Bigoni, Lorenzo Mancini, Amal Mawass, Federico Baraldi, Cristina Aljama, Marco Contoli, Marc Miravitlles
Arch Bronconeumol. 2024;60:269-78
5
Highlights

  • Treatment effects on PROs in chronic bronchitis (CB) with/out COPD are scarcely known.

  • N-acetylcysteine (NAC) improve symptoms and/or QoL in studies conducted in CB.

  • NAC reduce exacerbations in studies conducted in subjects with CB.

  • Similarly, NAC reduce exacerbations and improve symptoms and/or QoL in COPD studies.

Full text access
Open Article
5
Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population
Eduardo Loeb, Jan-Paul Zock, Marc Miravitlles, Esther Rodríguez, Juan José Soler-Cataluña, Joan B. Soriano, Francisco García-Río, Pilar de Lucas, ... Jaume Ferrer Sancho
Arch Bronconeumol. 2024;60:16-22
5
Full text access
Open Article
4
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis
Sumel Ashique, Neeraj Mishra, Ashish Garg, Nitish Kumar, Zuber Khan, Sourav Mohanto, Dinesh Kumar Chellappan, Arshad Farid, Farzad Taghizadeh-Hesary
Arch Bronconeumol. 2024;60 Supl 2:S46-S58
4
Full text access
4
Ultrasound in the Study of Thoracic Diseases: Innovative Aspects
Beatriz Romero Romero, Iván Vollmer Torrubiano, Jose Martín Juan, Sarah Heili Frades, Javier Pérez Pallares, Virginia Pajares Ruiz, Aurelio Wangüemert Pérez, Hernández Cristina Ramos, Enrique Cases Viedma
Arch Bronconeumol. 2024;60:33-43
4
Full text access
Open Article
3
Effect of CPAP Treatment on Cardiovascular Outcomes
Jordi de Batlle, Esther Gracia-Lavedán, Joan Escarrabill, Anna García-Altés, Elisenda Martinez Carbonell, Mario Henríquez-Beltrán, Manuel Sánchez-de-la-Torre, Ferran Barbé
Arch Bronconeumol. 2024;60:627-33
3
Full text access
3
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry
Alberto García Ortega, David Jiménez, Ana Pedro-Tudela, Cristina Pérez-Ductor, Carmen Fernández-Capitán, Conxita Falgá, Andris Skride, Carmine Siniscalchi, ... the RIETE investigators
Arch Bronconeumol. 2024;60:143-52
3
Full text access
Open Article
Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?